European Heart Journal

ISSN: 0195-668X

Journal Home

Journal Guideline

European Heart Journal Q1 Unclaimed

Oxford University Press United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The European Heart Journal is an international, English language, peer-reviewed journal dealing with cardiovascular medicine. It is an official journal of the European Society of Cardiology and is published weekly. The European Heart Journal aims to publish the highest quality material, both clinical and scientific, on all aspects of cardiovascular medicine. It includes articles related to research findings, technical evaluations, and reviews. In addition it provides a forum for the exchange of information on all aspects of cardiovascular medicine, including education issues. It has an SJR impact factor of 4,336.

European Heart Journal focuses its scope in these topics and keywords: heart, patients, coronary, disease, failure, myocardial, cardiovascular, atrial, artery, infarction, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3696 €

Gold OA


Green OA

0 €

Non OA


European Heart Journal


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Aims and Scope

heart, patients, coronary, disease, failure, myocardial, cardiovascular, atrial, artery, infarction, cardiac, treatment, clinical, fibrillation, familial, outcomes, prevention, review, liver, risk, study, syndromes, therapy, aortic, imaging,

Best articles

13-year follow-up of the German angioplasty bypass surgery investigation

View more

A novel monoclonal antibody targeting aggregated transthyretin facilitates its removal and functional recovery in an experimental model

View more

A paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy?

View more

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

View more

Accuracy of dual-source computed tomography to identify significant coronary artery disease in patients with atrial fibrillation: comparison with coronary angiography

View more

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

View more

Arrhythmogenic right ventricular cardiomyopathy: evidence for progression increases

View more

Association of lipoproteins with cytokines and cytokine receptors in heart failure patients Differences between ischaemic versus idiopathic cardiomyopathy

View more

Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation

View more

Authors reply to the letter titled: 'Mortality in congestive heart failure complicated by atrial fibrillation'

View more

Beta-blockers, psychological influences and erectile dysfunction: Reply

View more

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation

View more

CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke

View more

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol

View more

Chagas cardiomyopathy: Europe is not spared!

View more

Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?

View more

Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis

View more

Chlamydial endocarditis: a report on ten cases

View more

Chronic heart failure: pathophysiology and therapeutic approaches - why is the kidney so important?

View more

Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response

View more

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease A meta-analysis of randomized controlled trials

View more

Comments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases

View more

Comments on the European guidelines on cardiovascular disease prevention

View more

Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk

View more


No comments ... Be the first to comment!